News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
512,537 Results
Type
Article (9950)
Company Profile (142)
Press Release (502214)
Multimedia
Podcasts (7)
Webinars (8)
Section
Business (173229)
Career Advice (348)
Deals (26663)
Drug Delivery (23)
Drug Development (55671)
Employer Resources (15)
FDA (10580)
Job Trends (9029)
News (249875)
Policy (21148)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (631)
Accelerated approval (29)
ADA (19)
Adcomms (1)
Allergies (113)
Alliances (34619)
ALS (133)
Alzheimer's disease (1045)
Antibody-drug conjugate (ADC) (313)
Approvals (11325)
Artificial intelligence (351)
ASCO (170)
Autoimmune disease (231)
Automation (31)
Bankruptcy (274)
Belgium (1)
Best Places to Work (7334)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (188)
BioSpace Insights (21)
Biotechnology (92)
Bispecific (1)
Bladder cancer (152)
Brain cancer (45)
Breast cancer (544)
Cancer (4031)
Cardiovascular disease (260)
Career advice (289)
Career pathing (2)
CAR-T (184)
CDC (4)
CDMO (19)
Celiac Disease (1)
Cell therapy (509)
Cervical cancer (36)
Clinical research (50556)
Collaboration (1356)
Commercialization (3)
Compensation (1540)
Complete response letters (38)
COVID-19 (981)
CRISPR (69)
C-suite (840)
Cystic fibrosis (96)
Data (6183)
Denatured (4)
Depression (111)
Dermatology (74)
Diabetes (386)
Diagnostics (4433)
Digital health (41)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (175)
Drug pricing (36)
Drug shortages (6)
Duchenne muscular dystrophy (183)
Earnings (76411)
Editorial (3)
Employer branding (2)
Employer resources (16)
Events (91363)
Executive appointments (752)
FDA (13548)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (1029)
Gene editing (134)
Generative AI (13)
Gene therapy (349)
GLP-1 (343)
Government (2272)
Grass and pollen (3)
Guidances (307)
Healthcare (10423)
Hematology (97)
HIV (62)
Huntington's disease (25)
IgA nephropathy (70)
Immunology and inflammation (117)
Immuno-oncology (69)
Indications (175)
Infectious disease (1190)
Inflammatory bowel disease (136)
Inflation Reduction Act (4)
Influenza (89)
Intellectual property (271)
Interviews (48)
IPO (12813)
IRA (5)
Job creations (2090)
Job search strategy (277)
JPM (1)
Kidney cancer (21)
Labor market (1)
Layoffs (88)
Leadership (1)
Legal (5497)
Licensing (19)
Liver cancer (52)
Longevity (19)
Lung cancer (569)
Lymphoma (287)
Machine learning (31)
Management (3)
Manufacturing (623)
Marketing (8)
MASH (119)
Medical affairs (2)
Medical device (9338)
Medtech (9505)
Mergers & acquisitions (14948)
Metabolic disorders (790)
mRNA (74)
Multiple sclerosis (114)
NASH (4)
Netherlands (1)
Neurodegenerative disease (242)
Neuropsychiatric disorders (43)
Neuroscience (2008)
NextGen: Class of 2026 (3322)
Non-profit (1230)
Now hiring (1)
Obesity (261)
Opinion (24)
Ovarian cancer (179)
Pain (187)
Pancreatic cancer (220)
Parkinson's disease (215)
Partnered (12)
Patents (533)
Patient recruitment (570)
Patient selection (2)
Peanut (40)
People (42998)
Peptides (4)
Pharmaceutical (31)
Pharmacy benefit managers (12)
Phase 1 (15972)
Phase 2 (22375)
Phase 3 (15742)
Pipeline (8223)
Policy (41)
Postmarket research (1702)
Preclinical (6720)
Press Release (35)
Prostate cancer (212)
Psychedelics (10)
Radiopharmaceuticals (222)
Rare diseases (629)
Real estate (3235)
Recruiting (8)
Regenerative medicine (2)
Regulatory (16980)
Reports (28)
Research institute (719)
Resumes & cover letters (49)
Rett syndrome (42)
RNA editing (6)
RSV (50)
Schizophrenia (120)
Series A (169)
Series B (127)
Service/supplier (6)
Sickle cell disease (66)
Special edition (1)
Spinal muscular atrophy (93)
Sponsored (8)
Startups (2115)
Stomach cancer (3)
Supply chain (58)
Tariffs (14)
The Weekly (3)
Vaccines (447)
Venture capital (22)
Weight loss (99)
Women's health (97)
Worklife (2)
Date
Today (81)
Last 7 days (305)
Last 30 days (1538)
Last 365 days (20083)
2026 (14503)
2025 (20224)
2024 (24119)
2023 (27808)
2022 (36931)
2021 (40140)
2020 (36299)
2019 (25687)
2018 (19396)
2017 (20081)
2016 (19247)
2015 (25580)
2014 (22483)
2013 (18753)
2012 (20778)
2011 (21026)
2010 (20875)
Location
Africa (289)
Alabama (79)
Alaska (3)
Arizona (316)
Arkansas (11)
Asia (19691)
Australia (2639)
California (12466)
Canada (3827)
China (597)
Colorado (507)
Connecticut (438)
Delaware (229)
Europe (30640)
Florida (1891)
Georgia (395)
Hawaii (3)
Idaho (49)
Illinois (762)
India (67)
Indiana (390)
Iowa (22)
Japan (451)
Kansas (103)
Kentucky (32)
Louisiana (28)
Maine (28)
Maryland (1286)
Massachusetts (8289)
Michigan (316)
Minnesota (586)
Mississippi (4)
Missouri (100)
Montana (21)
Nebraska (13)
Nevada (125)
New Hampshire (64)
New Jersey (2969)
New Mexico (12)
New York (2952)
North Carolina (1357)
North Dakota (4)
Northern California (6286)
Ohio (319)
Oklahoma (14)
Oregon (19)
Pennsylvania (2377)
Puerto Rico (21)
Rhode Island (30)
South America (483)
South Carolina (78)
South Dakota (1)
Southern California (5173)
Tennessee (131)
Texas (2078)
United States (41149)
Utah (377)
Vermont (2)
Virginia (162)
Washington D.C. (38)
Washington State (967)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
512,537 Results for "sandoz canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sandoz Canada receives Health Canada regulatory approval for (Pr)Sandoz® Semaglutide, a generic version of (Pr)Ozempic®
September 18, 2026
·
4 min read
Press Releases
Sandoz Canada launches first ophthalmology biosimilar
February 2, 2026
·
3 min read
Press Releases
mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
September 18, 2026
·
2 min read
Manufacturing
Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
The company is investing billions of dollars to construct a European biosimilar hub capable of supporting the rapid expansion of its portfolio.
September 9, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
The initial batch of biosimilars includes copies of Amgen, Eli Lilly and GSK drugs that collectively generate billions of dollars in annual revenues.
August 18, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Sandoz Canada launches PrSandoz® Sacubitril-Valsartan, expanding access to heart failure treatments
October 2, 2025
·
5 min read
Press Releases
Médunik Canada enters into exclusive promotional services agreement with Biocodex for Diacomit® in Canada
September 3, 2026
·
4 min read
Press Releases
Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
September 3, 2026
·
3 min read
Press Releases
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
July 15, 2026
·
2 min read
Press Releases
LEO Pharma Inc. (Canada) Finalizes Letter of Intent with pCPA for Anzupgo® (delgocitinib cream) for Chronic Hand Eczema
September 9, 2026
·
5 min read
1 of 51,254
Next
